The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered Signals  by Hitotsumatsu, Osamu et al.
Immunity
ArticleThe Ubiquitin-Editing Enzyme A20 Restricts
Nucleotide-Binding Oligomerization
Domain Containing 2-Triggered Signals
Osamu Hitotsumatsu,1 Regina-Celeste Ahmad,1 Rita Tavares,1 Min Wang,1 Dana Philpott,2,3 Emre E. Turer,1
Bettina L. Lee,1 Nataliya Shiffin,1 Rommel Advincula,1 Barbara A. Malynn,1 Catherine Werts,2,4 and Averil Ma1,5,*
1UCSF Colitis Center, Gastroenterology Division, Department of Medicine, Program in Biomedical Sciences,
University of California at San Francisco, San Francisco, CA 94143-0538, USA
2Groupe d’Immunite´ Inne´e et Signalisation, Institut Pasteur, Paris, France
3Present address: Department of Immunology, MSB, University of Toronto, 1 King’s College Circle, Toronto, Ontario M5S 1 A8, Canada.
4Present address: Unite de recherche Responses pre´coces aux Parasites et Immunopathologie, Institut Pasteur,
25 Rue du Dr. Roux, 75724 Paris cedex 15, France.
5Present address: University of California at San Francisco, 513 Parnassus Ave, S-1057, San Francisco, CA 94143-0538, USA.
*Correspondence: averil.ma@ucsf.edu
DOI 10.1016/j.immuni.2008.02.002SUMMARY
Muramyl dipeptide (MDP), a product of bacterial
cell-wall peptidoglycan,activates innate immunecells
by stimulating nucleotide-binding oligomerization
domain containing 2 (NOD2) -dependent activation
of the transcription factor NFkB and transcription of
proinflammatory genes. A20 is a ubiquitin-modifying
enzyme that restricts tumor necrosis factor (TNF) re-
ceptor and Toll-like receptor (TLR) -induced signals.
We now show that MDP induces ubiquitylation of
receptor- interacting protein 2 (RIP2) in primary mac-
rophages.A20-deficient cells exhibit dramatically am-
plified responses to MDP, including increased RIP2
ubiquitylation, prolonged NFkB signaling, and in-
creased production of proinflammatory cytokines. In
addition, in vivo responses to MDP are exaggerated
in A20-deficient mice and in chimeric mice bearing
A20-deficient hematopoietic cells. These exagger-
ated responsesoccur independently of theTLRadap-
tors MyD88 and TRIF as well as TNF signals. These
findings indicate that A20 directly restricts NOD2
induced signals in vitro and in vivo, and provide new
insights into how these signals are physiologically
restricted.
INTRODUCTION
Innate immune cells use a variety of molecules to sense the
presence of microbes and trigger protective innate and adaptive
immune responses. Hence, the regulation of signals induced by
these molecules is central both to the regulation of inflammatory
responses and immune homeostasis. Toll-like receptors (TLRs)
are the best characterized family of cell-surface microbial
sensors, and recent studies have revealed signaling proteins
that are essential for activation of TLR signaling as well as thosethat are required for restricting TLR signals (Akira and Takeda,
2004; Liew et al., 2005). More recent studies have revealed
a family of proteins called NOD (nuclear-binding and oligomeri-
zation domain) like proteins or CATERPILLER (Caspase recruit-
ment domain, transcription enhancer, R [purine]-binding, pyrin,
lots of leucine repeats) proteins, which sense intracellular micro-
bial products such as L-Ala-D-Glu-meso-diaminopimelic acid
(Tri-DAP) and muramyl dipeptide (MDP) (Girardin et al., 2003a,
2003b; Inohara et al., 2003; Ting et al., 2006; Fritz et al., 2006).
MDP stimulates NFkB signaling and the activation of innate
immune cells through a series of signaling events that require
NOD2 (Kobayashi et al., 2005), RIP2, or RICK (Inohara et al.,
1998; Kobayashi et al., 2002; Chin et al., 2002; Park et al.,
2007) and IkappaB kinase gamma (IKKg). Activation of NOD2
by MDP is thought to lead to recruitment of RIP2 via homotypic
interactions between caspase recruiting domains (CARDs) of
NOD2 and RIP2 (Inohara et al., 2000; Manon et al., 2007). IKKg
may subsequently be ubiquitylated and recruited to this signal-
ing complex, after which it phosphorylates IkappaBa (IkBa) to
release NFkB and induce NFkB-dependent transcriptional activ-
ity (Abbott et al., 2004). Although these studies have begun to
define the biochemical mechanisms by which NOD2 activates
NFkB, very little is known about how MDP- and NOD2-induced
signals are restrained. As with TLR signaling, negative regulators
of NOD2 signaling likely play important roles in regulating innate
immunity and immune homeostasis (Liew et al., 2005).
The regulation of intracellular signaling pathways involves
carefully coordinated series of rapid and reversible posttransla-
tional modifications of proteins. Polyubiquitin chains can be built
on target proteins via linkages through any of the seven lysine
residues on ubiquitin, resulting in polyubiquitin chains of distinct
conformations (Weissmann, 2001; Pickart, 2004). These distinct
types of ubiquitin chains can target proteins for proteolysis via
proteosomal complexes and can also recruit additional signaling
proteins to active complexes or influence their localization to
subcellular compartments (Chen, 2005; Chen et al., 1995; Liu
et al., 2005; Deng et al., 2000). Protein ubiquitylation is enzymat-
ically regulated by the concerted actions of E1, E2, and E3
ligases, which add ubiquitin molecules to target proteins, andImmunity 28, 381–390, March 2008 ª2008 Elsevier Inc. 381
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A20 restricts RIP2 ubiquitylation and NOD2 signalsFigure 1. A20 Inhibits MDP- and DAP-Dependent NFkB
Transcriptional Activity
(A–C) NFkB-dependent luciferase reporter assays of NOD2 or
NOD1 transfected 293T cells. Indicated amounts of (A) NOD2,
(B) NOD1, or (C) cAMP response element (CRE) plasmid trans-
fected 293T cells were stimulated with MDP, Tri-DAP, or forskolin,
respectively. Cells were also cotransfected with either 0 ng (black
columns), 5 ng (gray columns), or 25 ng (white columns) of an A20
expression plasmid. Note the induction of NOD2-mediated NFkB
transcriptional activity by MDP, the induction of NOD1-mediated
NFkB by Tri-DAP, and the dose-dependent inhibition of these in-
ductions by A20. By contrast, forskolin induced cAMP response
element driven luciferase activity is not suppressed by A20. Data
are reported in relative luciferase units (RLU) and are representa-
tive of three independent experiments.
(D and E) A20 is required for restricting MDP induced responses.
ELISA analyses of secreted IL-1b and IL-6 from BMDCs. BMDCs
from Tnfaip3+/+ (white columns) and Tnfaip3/ (black columns)
mice were stimulated with the indicated doses of MDP for 12,
24, or 36 hr (for IL-6 analyses) or 24 hr (for IL-1b analyses), after
which supernatants were harvested and analyzed by ELISA for
(D) IL-6 and (E) IL-1b secretion. Data are representative of three in-
dependent experiments, with standard deviation (bars) indicated.deubiquitinating enzymes (DUBs), which deconjugate ubiquitin
chains. The physiological importance of ubiquitylation events
in regulating cellular signaling and homeostasis has recently
been highlighted by studies in which enzymes responsible for
adding or removing ubiquitin chains have been genetically de-
leted. The elimination of E3 ligases or DUBs from mice can result
in either hypomorphic or excessive cell-signaling phenotypes
(Lee et al., 2000; Naka et al., 1998; Chiang et al., 2000; Massoumi
et al., 2006). Hence, these enzymes play critical roles in regulat-
ing signal-transduction pathways.
The A20 protein is critical for preventing inflammation in vivo
(Opipari et al., 1990; Krikos et al., 1992; Lee et al., 2000). A20-
or Tnfaip3-deficient (Tnfaip3/) mice spontaneously develop
severe inflammation, cachexia, and die prematurely, even in
the absence of adaptive T and B lymphocytes (Lee et al.,
2000). The physiological functions of A20 in regulating innate
immune homeostasis are likely related to A20’s essential roles
in restricting both tumor necrosis factor (TNF) and Toll-like
receptor (TLR) -induced NFkB signaling (Lee et al., 2000; Boone
et al., 2004). A20 may perform these critical functions by both
deubiquitylating K63 linked polyubiquitin chains and adding
K48 linked polyubiquitin chains to the signaling proteins RIP1
and TRAF6 (Lee et al., 2000; Boone et al., 2004; Wertz et al.,
2004). In addition to its profound biological roles in experimental
models, A20 may also play important roles in human autoim-
mune diseases. Recent genetic studies suggest that polymor-
phisms in or near the human tnfaip3 (A20) gene are associated
with rheumatoid arthritis and possibly Crohn’s disease (Well-
come Trust Case Control Consortium, 2007; Plenge et al.,
2007; Thomson et al., 2007). Given the ability of A20 to restrict
TNF- and TLR-induced NFkB signals and the genetic associa-
tion of polymorphisms in the TNFAIP3 (A20) and NOD2 genes
with human inflammatory diseases, we have examined whether
and how A20 may regulate NOD2-induced signaling.382 Immunity 28, 381–390, March 2008 ª2008 Elsevier Inc.RESULTS
A20 Can Inhibit MDP-Induced NFkB Activity
MDP activates innate immune cells by activating NFkB-depen-
dent transcription of proinflammatory genes. As previously
reported, transfection of NOD2 into 293T cells confers respon-
siveness to MDP, as reflected by NFkB-dependent luciferase
activity (Girardin et al., 2003b; Inohara et al., 2003). To begin to
examine whether A20 inhibits MDP-induced NFkB transcrip-
tional activity, we cotransfected NOD2 expression and NFkB-
luciferase reporter plasmids into 293T cells. These experiments
indicated that increasing amounts of NOD2 plasmid led to
increasing amounts of NFkB activity. Additional cotransfection
of an A20 expression construct dramatically inhibited this
MDP- and NOD2-dependent NFkB activity, indicating that A20
can inhibit this signaling pathway (Figure 1A). A20 also inhibited
NFkB signaling induced by Tri-DAP and NOD1, suggesting that
A20 may restrict signaling events common to NOD1- and
NOD2-dependent NFkB signaling (Figure 1B). A20 did not inhibit
forskolin induced cyclic AMP response element (CRE) -depen-
dent transcription, indicating that A20 does not globally inhibit
transcriptional activation or luciferase production in these as-
says (Figure 1C). Taken together, these results suggest that A20
inhibits MDP and NOD-dependent NFkB activity.
A20 Is Required for Restricting MDP-Induced Signals
To determine whether the ability of A20 to inhibit MDP triggered
NFkB transcription correlates with a physiological requirement
for A20 to restrict MDP-stimulated signals, we tested the
responses of Tnfaip3/ and Tnfaip3+/+ bone marrow-derived
dendritic cells (BMDCs) to MDP. Notably, Tnfaip3/ and
Tnfaip3+/+ BMDCs were phenotypically similar, as judged by
the expression of CD11c, CD40, and MHC class II molecules, af-
ter 10 days of culture in GM-CSF containing media (Figure S1).
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at day 10 of culture revealed thatTnfaip3/ BMDCs secrete
more IL-6 and more IL-1b than Tnfaip3+/+ BMDCs, indicating
that A20 is required for restricting MDP-triggered inflammatory
responses (Figures 1D and 1E).
A20 Is Required for Restricting MDP-Induced
NFkB-Signaling Activity
MDP stimulates NFkB-signaling activity, which in turn leads to
the production of NFkB-dependent genes such as IL-6 and
IL-1b. We thus investigated whether A20 is directly required
for restricting MDP-induced NFkB-signaling activity. Bone
marrow-derived macrophages (BMDMs) from Tnfaip3+/+ and
Tnfaip3/ mice were stimulated with MDP, after which cell
lysates were acutely analyzed by immunoblotting for IkBa and
phospho-IkBa protein expression as indicators of NFkB-signal-
ing activity. As compared to Tnfaip3+/+ BMDMs, Tnfaip3/ cells
express elevated amounts of phospho-IkBa protein, suggesting
that A20 is physiologically required for restricting MDP-induced
NFkB signaling (Figure 2A). To confirm that A20 was required for
proximate NFkB-signaling activity, we analyzed the activity of
the IKK signalosome by performing IKK kinase assays on lysates
from MDP stimulated Tnfaip3+/+ and Tnfaip3/ cells. These
experiments revealed that Tnfaip3/ cells displayed exagger-
ated IKK kinase activity when compared to Tnfaip3+/+ cells
(Figure 2B). As these assays measure acute signaling events,
these findings suggest that A20 plays a direct role in terminating
MDP-induced NFkB signaling.
As A20 protein is induced by LPS in macrophages, we exam-
ined whether A20 is also induced by MDP in these cells (Boone
et al., 2004). MDP treatment did not substantially change the
basal level of A20 protein expression in BMDMs, consistent
with the fact that MDP causes much weaker stimulation of
NFkB signaling in macrophages than LPS (Figure 2A). MDP
responses in macrophages are thought to depend upon NOD2
and RIP2. We thus examined whether expression of these
proteins are affected by A20 deficiency. These studies revealed
that both NOD2 and RIP2 proteins were expressed at similar
levels in Tnfaip3+/+ and Tnfaip3/ cells and did not change
significantly after MDP stimulation (Figure 2A). Considered
together with the findings above, A20 appears to directly regu-
late MDP-induced NFkB signaling at or above the level of the
IKK signalsome.
A20 Directly Restricts MDP-Induced NFkB Signaling
Activity, Independently of LPS or TNF Signals
Some sources of MDP can be contaminated with LPS, and as
A20 restricts LPS-induced NFkB signaling, we sought to rule
out the possibility that Tnfaip3/ cells were aberrantly respond-
ing to contaminating LPS, rather than MDP, in our assays. First,
we pretested batches of MDP using a sensitive limulus endo-
toxin assay and utilized endotoxin-free MDP for our signaling
studies. Second, we obtained an MDP isomer that does not
activate NOD2 from the same commercial source as the active
MDP. We tested the ability of this MDP isomer to stimulate
NFkB signals in wild-type BMDMs. This experiment revealed
that the inactive MDP isomer fails to induce phospho-IkBa,
consistent with the absence of contaminating LPS from this
source (Figure 3A). Third, as the adaptor protein MyD88 isrequired for most TLR-induced NFkB signaling and is not thought
to be involved in NOD-induced signals, we tested the responses
of BMDMs from Tnfaip3+/+ Myd88/ and Tnfaip3/ Myd88/
double-mutant mice to MDP. These experiments showed that
Tnfaip3/ Myd88/ BMDMs exhibited exaggerated NFkB-
signaling responses to MDP when compared with Tnfaip3+/+
Myd88/cells (Figure 3B). Thus, A20 regulates NOD2 responses
independently of MyD88-dependent TLR signals. Finally,
MyD88-independent TLR signals are mediated by an alternative
adaptor, TRIF (Hoebe et al., 2003; Yamamoto et al., 2003). To ex-
amine A20s role in regulating MDP signaling in the absence of all
TLR signals, we interbred Tnfaip3/ Myd88/ mice with
Ticam1lps2/lps2 mutant mice that lack TRIF-dependent signaling.
We then tested MDP responses in Tnfaip3/ Myd88/
Ticam1lps2/lps2 and Tnfaip3+/+ Myd88/ Ticam1lps2/lps2 BMDMs.
This experiment revealed that MDP induces exaggerated NFkB
signaling in Tnfaip3/Myd88/ Ticam1lps2/lps2 cells when com-
pared to Tnfaip3+/+ Myd88/ Ticam1lps2/lps2 cells (Figure 3C).
Together, these results show that A20 regulates MDP-induced
signals independently of TLR signals.
A20 regulates TNF-induced NFkB signals, and MDP stimula-
tion of BMDMs can stimulate modest levels of TNF secretion.
To ensure that prolonged NFkB-signaling activity in Tnfaip3/
Figure 2. A20 Is Required for Restricting MDP-Induced Signaling
Activity
(A) Immunoblotting analyses of phospho-IkBa, IkBa, A20, NOD2, RIP2, and
actin protein expression in Tnfaip3/ and Tnfaip3+/+ BMDMs after MDP
stimulation. Tnfaip3/ and Tnfaip3+/+ BMDMs were stimulated with 10 mg/ml
of MDP, and cell lysates were harvested at the indicated time points for
immunoblotting analysis. Note increased phospho-IkBa protein expression
in Tnfaip3/ cells at later time points, indicating prolonged NFkB-signaling
activity. Note similar amounts of IkBa, NOD2, and RIP2 in Tnfaip3+/+ and
Tnfaip3/ cells after MDP stimulation. Note constant A20 protein expression
in Tnfaip3+/+ cells (and not in Tnfaip3/ cells) after MDP stimulation. Actin
protein expression is shown as a control.
(B) IKK kinase assay of Tnfaip3/ and Tnfaip3+/+ BMDMs after MDP stimula-
tion. Tnfaip3/ and Tnfaip3+/+ BMDMs were stimulated with MDP, and cell ly-
sates were harvested at the indicated time points, immunoprecipitated with
anti-IKKg antibody, incubated with GST-IkBa substrate, and analyzed by
immunoblotting for phospho-GST-IkBa levels. Note increased phospho-
GST-IkBa expression in Tnfaip3/ BMDMs indicating prolonged IKK kinase
activity. IKKb protein expression in the immunoprecipitates are shown as
a control.
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these cells, we interbred Tnfaip3/ Myd88/ mice with Tnf/
mice and compared the MDP responses of Tnfaip3/Myd88/
Tnf/ BMDMs with Tnfaip3+/+ Myd88/ Tnf/ BMDMs. These
experiments showed that Tnfaip3/ Myd88/ Tnf/ BMDMs
exhibit exacerbated NFkB signaling compared with Tnfaip3+/+
Myd88/ Tnf/ BMDMs (Figure 3D). Taken together, these
experiments indicate that A20 directly restricts MDP-induced
NFkB signaling independently of TLR or TNF signals.
A20 Inhibits RIP2-Induced NFkB Transcriptional Activity
We then turned to investigate the mechanism by which A20
might restrict MDP-induced NFkB signaling. Prior studies
indicated that MDP-induced NFkB signaling requires RIP2 in
addition to NOD2 (Kobayashi et al., 2002, 2005; Chin et al.,
2002; Park et al., 2007). MDP induces NOD2 oligomerization
that leads to recruitment of RIP2. Activated RIP2 is thought to
recruit IKKg to this signaling complex and phosphorylates IkBa
to release NFkB and induce NFkB-dependent transcriptional
activity (Inohara et al., 2000; Abbott et al., 2004). We were inter-
ested in investigating whether A20 might inhibit NOD2-induced
signaling at or below the point of RIP2 activation. We thus tested
whether A20 could inhibit RIP2-induced NFkB activity by
cotransfecting RIP2, A20, and an NFkB-dependent luciferase
reporter into 293T cells and assaying luciferase production.
Transfection of RIP2 expression plasmid induces NFkB-depen-
dent luciferase activity in a dose-dependent fashion. Cotransfec-
tion of A20 expression plasmid suppressed RIP2-induced NFkB
transcriptional activity (Figure 4A). These studies indicate that
A20 inhibits RIP2-induced NFkB transcriptional activity in
a dose-dependent fashion. This result also suggests that A20
can restrict MDP-induced NFkB signaling at or below the point
of RIP2 in this pathway.
A20 Deubiquitylates RIP2, a Critical NOD2
Signaling Protein
To better understand the molecular mechanism by which A20
restricts MDP-induced NFkB signaling, we considered that
A20 is a ubiquitin-modifying enzyme that regulates RIP1 ubiqui-
tylation after TNFR signaling (Wertz et al., 2004). RIP2 shares a
kinase domain with RIP1. We thus hypothesized that RIP2 might
undergo ubiquitylation in response to MDP and that A20, a ubiq-
uitin-modifying enzyme, may regulate RIP2 ubiquitylation. To
test this hypothesis, we first investigated whether RIP2 could
be ubiquitylated in cells. We cotransfected FLAG-tagged RIP2
and myc-tagged forms of ubiquitin bearing either K48R or
K63R mutations into 293T cells, immunoprecipitated FLAG-
RIP2, and analyzed the ubiquitylation status of this protein by
immunoblotting. This experiment suggested that transfected
RIP2 can be ubiquitylated preferentially with K63 polyubiquitin
chains, a linkage that has been associated with protein activation
(Figure 4B).
We then asked whether A20 could regulate RIP2’s signaling
activity by regulating RIP2 ubiquitylation in cells. Cotransfection
of HA-RIP2 and myc-K48R mutant ubiquitin with wild-type A20
revealed that A20 reduced the amount and size of polyubiquity-
lated RIP2 (Figure 4C). By contrast, coexpression of a mutant
form of A20 bearing a cysteine to alanine mutation at position
103 (C103A), a mutation known to eliminate deubiquitylating384 Immunity 28, 381–390, March 2008 ª2008 Elsevier Inc.activity of A20, failed to reduce RIP2 ubiquitylation (Figure 4C).
This finding suggests that A20 deubiquitylates non-K48-linked
polyubiquitylated RIP2, thereby reducing its signaling activity.
Figure 3. A20 Directly Regulates MDP-Induced NFkB Signaling
(A) Immunoblotting analyses of MDP versus MDP isomer-stimulated BMDMs.
Wild-type BMDMs were stimulated with either MDP or an MDP isomer from the
same commercial source that does not activate NOD2 for the indicated time
points, after which lysates were analyzed for expression of phospho-IkBa.
Note that the MDP isomer fails to elicit NFkB signaling in BMDMs.
(B) Immunoblotting analyses of phospho-IkBa protein levels in Tnfaip3/
Myd88/ and Tnfaip3+/+ Myd88/ BMDMs after MDP stimulation.
Tnfaip3/ Myd88/ and Tnfaip3+/+ Myd88/ BMDMs were stimulated
with 10 mg/ml of MDP, and cell lysates were harvested at the indicated time
points for immunoblotting analysis. Note that increased phospho-IkBa protein
expression is observed in Tnfaip3/ Myd88/ cells at later time points,
indicating that A20 restricts MDP NFkB-signaling activity independently of
MyD88.
(C) Immunoblotting analyses of phospho-IkBa protein levels in Tnfaip3/
Myd88/ Ticam1lps2/lps2 and Tnfaip3+/+ Myd88/ Ticam1lps2/lps2 BMDMs
after MDP stimulation. Tnfaip3/ Myd88/ Ticam1lps2/lps2 and Tnfaip3+/+
Myd88/ Ticam1lps2/lps2 BMDMs were stimulated with 10 mg/ml of MDP,
and cell lysates were harvested at the indicated time points for immunoblotting
analysis of phospho-IkBa and IkBa. Note that increased phospho-IkBa protein
levels are observed in Tnfaip3/Myd88/ Ticam1lps2/lps2 BMDMs compared
with Tnfaip3+/+ Myd88/ Ticam1lps2/lps2 cells.
(D) Immunoblotting analyses of phospho-IkBa protein levels in Tnfaip3/
Myd88/ Tnf/ and Tnfaip3+/+ Myd88/ Tnf/ BMDMs after MDP stimula-
tion. Tnfaip3/ Myd88/ Tnf/ and Tnfaip3+/+ Myd88/ Tnf/ BMDMs
were stimulated with 10 mg/ml of MDP, and cell lysates were harvested at
the indicated time points for immunoblotting analysis of phospho-IkBa and
IkBa proteins. Note that increased phospho-IkBa protein levels are observed
in Tnfaip3/ Myd88/ Tnf/ BMDMs compared with Tnfaip3+/+ Myd88/
Tnf/ cells. Immunoblots for actin expression are shown as controls for all
experiments. All data are representative of at least three independent experi-
ments.
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NFkB Activity
(A) NFkB-dependent luciferase reporter assays of RIP2-transfected 293T
cells. 293T cells were transfected with either 0 ng (white columns), 5 ng (light
gray columns), 25 ng (dark gray columns), or 125 ng (black columns) of RIP2
expression plasmid and the indicated amounts of A20 expression plasmids.
(White columns are essentially at baseline.) Cell lysates were analyzed for
luciferase activity. Note the dose-dependent induction of NFkB transcriptional
activity by RIP2 and the dose-dependent inhibition of this induction by A20.
Data are reported in relative luciferase units and are representative of three
independent experiments.
(B) Immunoblotting assay of RIP2 ubiquitylation in cells. FLAG-tagged RIP2
and Myc-tagged ubiquitin were cotransfected into 293T cells, after which cells
were lysed in NP-40 buffer, and boiled in 1% SDS. Samples were then diluted
1:10 with PBS, immunoprecipitated with FLAG-specific antibody (RIP2), and
immunoblotted for the presence of Myc-ubiquitin. Note that RIP2 is preferen-
tially ubiquitylated with K48R ubiquitin compared to K63R ubiquitin in cells
(compare second and third lanes of top panel). Immunoblotting of Myc-
ubiquitin proteins in preimmunoprecipitates are shown in bottom panel as
controls.
(C) A20 restricts RIP2 ubiquitylation in cells. Immunoblotting analyses of RIP2
ubiquitylation with A20 cotransfection. HA-RIP2, Myc-K48R ubiquitin, and
either wild-type or mutant C103A A20 were cotransfected into 293T cells, after
which lysates were immunoblotted for Myc (ubiquitin). Note that cotrans-
fected wild-type A20 but not C103A mutant A20 reduces RIP2 ubiquitylation
in cells (top panels). Immunoblotting of Myc-ubiquitin proteins is shown in
bottom panel as controls.
(D) Recombinant A20 protein deubiquitylates RIP2 in a cell-free assay. Immu-
noblotting analyses of RIP2 ubiquitylation after cell-free deubiquitylation.
FLAG-RIP2 and myc-K48R mutant ubiquitin were cotransfected into 293T
cells, after which cells were lysed in NP-40 lysis buffer. Samples were then
immunoprecipitated with FLAG specific antibody (RIP2), washed, and incu-
bated with bacterial recombinant N-terminal A20 protein or mutant C103A
A20 protein for 90 min. Wild-type N-terminal A20 protein was also incubated
with ubiquitylated RIP2 in the presence of the cysteine protease inhibitor
N-ethyl maleimide (NEM). Reactions were then analyzed by immunoblottingThe reduction of polyubiquitylated RIP2 by cotransfected A20
in cells could be due to A20 deubiquitylating RIP2 or to A20
preventing the ubiquitylation of RIP2. To better determine
whether A20 directly removes ubiquitin chains from RIP2, we
cotransfected FLAG-RIP2 and myc-K48R ubiquitin into cells,
immunoprecipitated FLAG-RIP2, and tested the ability of bacte-
rially derived recombinant N-terminal A20 protein to deubiquity-
late RIP2 in a cell-free assay. Recombinant N-terminal A20
protein reduced the level of ubiquitylated RIP2, while a mutant
N-terminal A20 protein bearing a cysteine to alanine (C103A)
substitution exhibited reduced deubiquitylating activity (Fig-
ure 4D, compare first, second, and third lanes). In addition, N-
ethylemaleimide, a cysteine protease inhibitor that inhibits
A20’s deubiquitylating activity, inhibits A20’s activity toward
ubiquitylated RIP2 in these assays (Figure 4D, compare first,
second, and fourth lanes). These experiments indicate that A20
can directly deubiquitylate non-K48-linked ubiquitin chains
from RIP2. Thus, A20 may terminate MDP-induced NFkB signal-
ing by removing activating K63-linked polyubiquitin chains from
RIP2.
A20 Is Required for Restricting MDP-Induced
Ubiquitylation of Endogenous RIP2
The physiological role of A20 in regulating MDP-induced RIP2
ubiquitylation can be directly assessed by measuring the status
of endogenous RIP2 protein in Tnfaip3+/+ and Tnfaip3/ cells
after MDP stimulation. We thus treated Tnfaip3+/+ and
Tnfaip3/ BMDMs with MDP, lysed the cells at various time
points, boiled the lysates in 1% SDS, immunoprecipitated
RIP2, and tested the ubiquitylation status of RIP2 by immuno-
blotting for ubiquitin. These experiments reveal that MDP causes
ubiquitylation of endogenous RIP2 in both Tnfaip3+/+ and
Tnfaip3/ BMDMs (Figure 5A). Strikingly, the levels of ubiquity-
lated RIP2 are exaggerated and prolonged in Tnfaip3/BMDMs
after MDP treatment (Figure 5A). As these lysates were boiled in
1% SDS prior to immunoprecipitation, the ubiquitylated proteins
detected on the immunoblot should represent RIP2 and not
RIP2-associated proteins, such as TRAF6.
A20 can regulate TRAF6 ubiquitylation after TLR-induced
signals, and TRAF6 may contribute to NOD2- induced NFkB
signaling (Boone et al., 2004; Abbott et al., 2007). We thus tested
whether endogenous TRAF6 ubiquitylation was regulated by
A20 after MDP stimulation. We stimulated Tnfaip3+/+ and
Tnfaip3/ BMDMs with MDP, boiled lysates in 1%SDS, diluted
the samples, immunoprecipitated endogenous TRAF6 (instead
of RIP2), and immunoblotted for ubiquitin. These experiments
revealed that MDP induces negligible TRAF6 ubiquitylation in
Tnfaip3+/+ BMDMs, and no increased TRAF6 ubiquitylation is
seen in Tnfaip3/ BMDMs (Figure 5B). Thus, A20 is required
for restricting MDP-induced RIP2 and not TRAF6 ubiquitylation.
By contrast, stimulation of Tnfaip3+/+ and Tnfaip3/ BMDMs
with LPS readily induced TRAF6 ubiquitylation (data not shown).
for (Myc) ubiquitin. Note that wild-type A20 but not mutant C103A A20 protein
reduces RIP2 ubiquitylation (compare second and third lanes). Note also that
A20-mediated reduction of RIP2 ubiquitylation is inhibited by NEM (compare
second and fourth lanes). Data are representative of three independent
experiments.Immunity 28, 381–390, March 2008 ª2008 Elsevier Inc. 385
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ubiquitylation of RIP2 after MDP stimulation.
A20 Is Required for Restricting MDP Responses In Vivo
The ability of MDP to activate NOD2-expressing innate im-
mune cells suggests that MDP would stimulate inflammatory
responses in intact mice. We thus tested the responses of
Tnfaip3/ and Tnfaip3+/+ mice to MDP. Tnfaip3/ and
Tnfaip3+/+ mice were injected intraperitoneally with either MDP
or H2O, after which serum IL-6 protein was measured by ELISA.
These experiments revealed that MDP induced significantly
higher levels of serum IL-6 in Tnfaip3/ mice than in Tnfaip3+/+
mice (data not shown). To ensure that these responses were not
mediated by contaminating TLR ligands, we repeated these
studies with Tnfaip3/ Myd88/ and Tnfaip3+/+ Myd88/
mice. MDP again induced serum IL-6 production in these
mice, and the levels of IL-6 were dramatically higher in
Tnfaip3/ Myd88/ mice than in Tnfaip3+/+ Myd88/ mice
(Figure 6A). Thus, A20 restricts MDP responses in vivo in the
absence of MyD88-dependent TLR responses. This finding is
notable, as most prior studies of in vivo MDP responses have
relied upon accompanying TLR signals.
NOD2 is expressed in radiation-sensitive hematopoietic cells
such as macrophages and dendritic cells as well as in radiation
resistant cells such as Paneth cells. We thus investigated
whether A20 restricts MDP-induced IL-6 production specifically
in hematopoietic cells in vivo. We used either Tnfaip3/
Myd88/ or Tnfaip3+/+ Myd88/ fetal liver hematopoietic
stem cells (HSCs) to reconstitute irradiated wild-type mice,
allowed 6 weeks for hematopoietic reconstitution, and then
tested the responses of these radiation chimera to MDP. These
experiments revealed that Tnfaip3/ Myd88/ HSC reconsti-
tuted chimera elaborated greater amounts of serum IL-6 than
Figure 5. A20 Is Required for Restricting Endogenous RIP2 and Not
TRAF6 Ubiquitylation after MDP Stimulation
(A) Immunoblotting analysis of endogenous ubiquitylated RIP2 in BMDMs after
MDP stimulation. Tnfaip3/ and Tnfaip3+/+ BMDMs were stimulated with
10 mg/ml MDP and lysed in RIPA lysis buffer at the indicated time points, boiled
in 1%SDS, diluted 1:10 with RIPA buffer, and immunoprecipitated with
anti-RIP2 antibody. Immunoprecipitated RIP2 was then analyzed by immuno-
blotting for ubiquitin. Note the presence of prolonged RIP2 ubiquitylation in
Tnfaip3/ BMDMs after MDP stimulation. Immunoblotting of RIP2 immuno-
precipitates is shown below as a control.
(B) Immunoblotting analysis of endogenous ubiquitylated TRAF6 in BMDMs
after MDP stimulation. Tnfaip3/ and Tnfaip3+/+ BMDMs were stimulated
as in (A) above and immunoprecipitated with anti-TRAF6 antibody. Immuno-
precipitated TRAF6 was then analyzed by immunoblotting for ubiquitin. Note
similar TRAF6 ubiquitylation in Tnfaip3+/+ and Tnfaip3/ BMDMs after MDP
stimulation. Immunoprecipitates using antibody-coated beads only (no
lysates) are shown as controls in right lane of each immunoblot. Immunoblot-
ting for TRAF6 on TRAF6 immunoprecipitates is shown below as a control.
Data are representative of seven independent experiments.386 Immunity 28, 381–390, March 2008 ª2008 Elsevier Inc.Tnfaip3+/+ Myd88/ HSC reconstituted chimera after MDP
injection (Figure 6B). Thus, consistent with our in vitro studies,
A20 expression in hematopoietic cells is required for restricting
MDP-induced NOD2 signaling in vivo.
DISCUSSION
We have identified a unique mechanism by which NOD2-
induced signaling and innate immune responses are restricted.
Our results suggest that ubiquitylation of RIP2 is a physiological
event in macrophages in response to MDP- and NOD2-induced
signals, and that the ubiquitin-modifying enzyme A20 is essential
for deubiquitylating RIP2 and negatively regulating these signals.
These findings provide new insights into how innate immune
responses are regulated by non-TLR ligands and signaling.
The recognition of microbial products through non-TLR host
proteins such as NOD or CATERPILLER proteins has emerged
as an important aspect of innate immunity. The requirement for
Figure 6. A20 Restricts MDP-Induced Inflammatory Responses
In Vivo
(A and B) ELISA analyses of serum from MDP-injected mice. Twenty-five milli-
grams over kilograms of MDP (or H2O) was injected into (A) intact Tnfaip3+/+
Myd88/ and Tnfaip3/Myd88/ mice, and (B) chimeric mice reconstituted
with HSCs from Tnfaip3+/+ Myd88/ and Tnfaip3/ Myd88/ mice. Serum
was harvested 4 hr after MDP injection and analyzed for IL-6 levels by ELISA.
White columns indicate samples from mice injected with H2O, and indicate
that no IL-6 above baseline was detected (ND). Black columns indicate
samples from MDP-injected mice. Note increased levels of serum IL-6 in (A)
intact Tnfaip3/ Myd88/ mice compared with Tnfaip3+/+ Myd88/ mice
and in (B) chimeric mice bearing Tnfaip3/ Myd88/ HSCs compared with
those bearing Tnfaip3+/+ Myd88/ cells. Data were obtained from three
sets of paired mice.
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A20 restricts RIP2 ubiquitylation and NOD2 signalsA20 in restricting MDP- and NOD2-induced signals demon-
strates that these signals, like TLR signals, are physiologically
restricted by endogenous proteins. A recent study suggests
that a short isoform of NOD2, NOD2-S, may also restrict
NOD2-induced signals (Rosenstiel et al., 2006). In addition,
certain members of the CATERPILLER family appear to nega-
tively regulate cellular activation of immune cells (Ting et al.,
2006). Hence, the proper regulation of these signaling pathways
requires both positive and negative regulators.
Prior studies suggested that both NOD2 and RIP2 are essen-
tial for MDP-induced NFkB responses (Girardin et al., 2003b;
Kobayashi et al., 2002, 2005; Chin et al., 2002; Park et al.,
2007). MDP was thought to activate NFkB signaling by inducing
NOD2 oligomerization, RIP2 recruitment, IKKg recruitment, and
IKKg ubiquitylation (Inohara et al., 2000; Abbott et al., 2004). How
RIP2 becomes biochemically activated was unknown. Our
current studies suggest that RIP2 is physiologically ubiquitylated
in primary cells after ligand stimulation. RIP2 may be ubiquity-
lated with non-K48-linked polyubiquitin chains that help recruit
downstream signaling molecules such as IKKg. As IKKg binds
polyubiquitylated RIP1 during TNF receptor-induced NFkB
signaling, it is possible that IKKg binds to polyubiquitylated
RIP2 in a similar fashion during MDP-induced NFkB signaling
(Ea et al., 2006; Wu et al., 2006). Recruitment of IKKg would
then lead to IkBa phosphorylation and NFkB transcriptional
activity. The identification of RIP2 ubiquitylation has also been
shown by others during the review of this study (Hasegawa
et al., 2008; Yang et al., 2007). Together, these studies provide
an important new insight for understanding MDP- and NOD2-
induced NFkB signaling.
We have shown that A20 is required for restricting MDP-
induced cytokine production and NFkB signaling in primary
innate immune cells. These findings demonstrate that NOD2-
induced signals are physiologically restricted. Thus, it appears
that NOD2 signaling, like TLR signaling, requires negative as
well as positive regulation. In addition, we have elucidated a bio-
chemical mechanism by which A20 may restrict NOD2 signals.
A20 can directly deubiquitylate non-K48-linked chains on RIP2,
and A20 is required for physiologically restricting endogenous
RIP2 ubiquitylation after MDP stimulation. As RIP2 may become
conjugated with K63-linked polyubiquitin chains after MDP stim-
ulation, A20’s deubiquitylating activity may serve to ‘‘deactivate’’
RIP2. It is also possible that A20 may utilize its E3 ligase activity
to remove ubiquitylated RIP2 from active signaling complexes.
Both of these activities would serve to terminate NOD2-induced
NFkB signaling. These RIP2-targeted activities could also
explain A20’s apparent role in restricting NOD1-induced NFkB
signaling, which also requires RIP2 (Girardin et al., 2003a).
Although A20 does not stably associate with RIP2 in cells (data
not shown), it is not uncommon for ubiquitin-modifying enzymes
to associate only transiently with their substrates. The combina-
tion of our findings that A20 can directly deubiquitylate RIP2 in
cell-free assays and that endogenous RIP2 ubiquitylation is
exaggerated in MDP stimulated Tnfaip3/ cells provides com-
pelling evidence that RIP2 is the predominant physiological
substrate for A20 in the MDP-/NOD2-signaling pathway.
Our current studies show that purified MDP elicit inflammatory
responses in vivo independently of TLR signaling. We have used
Tnfaip3/ Myd88/ and Tnfaip3/ Myd88/ Ticam1lps2/lps2mice to establish that MDP elicits proinflammatory responses
in the absence of MyD88- and TRIF-dependent TLR signaling
and to show that A20 restricts NOD2 signaling independently
of its roles in inhibiting TLR signaling. The genetic dissection of
TLR- and NOD2-induced signaling is important since NOD2
signals have been suggested to both enhance and restrict
MyD88-dependent TLR signals (Netea et al., 2005; Wolfert
et al., 2002; Watanabe et al., 2004). Our finding thus provides
new avenues for genetically dissecting the physiological roles
of A20 in regulating NOD2 versus TLR signaling as well as for
understanding the interactions between TLR and NOD2 signal-
ing. Moreover, the ability to elicit MDP responses in intact mice
should facilitate further studies interrogating the roles of
NOD2-induced signaling in vivo. For example, dissecting the
physiological roles of NOD2-induced signals in distinct cell types
such as epithelial cells and macrophages can be addressed in
chimeric mice or mice bearing lineage-specific gene deletions
of NOD2-signaling proteins.
NOD2 signaling is likely to be important to immune homeosta-
sis, because polymorphisms in the human NOD2 gene are asso-
ciated with both Blau’s syndrome and Crohn’s disease in human
patients (Miceli-Richard et al., 2001; Hugot et al., 2001; Ogura
et al., 2001). However, multiple questions remain in understand-
ing this association. NOD2 polymorphisms have been proposed
to exhibit both loss and gain of NOD2 function (Miceli-Richard
et al., 2001; Watanabe et al., 2004; Maeda et al., 2005), and it
is unclear precisely how hypomorphic or hypermorphic muta-
tions in NOD2 predispose patients to intestinal inflammation.
Nevertheless, the clearest physiological function for NOD2 is
mediating cellular responses to MDP by activating NFkB signal-
ing. Hence, understanding the molecular mechanisms by which
NOD2 activates NFkB signaling and how this process is regu-
lated will likely provide critical insights into how perturbations
in NOD2 function affect cellular and ultimately organismal
responses. In this context, our discovery that A20 is directly
responsible for restricting MDP-triggered signals provides both
an important molecular insight into physiological NOD2 function,
but also a potential therapeutic target for manipulating or
correcting NOD2 functions. Greater understanding of how
NOD2-mediated signals regulate immune responses and
homeostasis is likely to be biomedically as well as immunologi-
cally important.
We have previously shown that A20 restricts TNF and TLR
signals by regulating the ubiquitylation of RIP1 and TRAF6,
respectively (Lee et al., 2000; Boone et al., 2004; Wertz et al.,
2004). Our current studies suggest that A20 is also physiologi-
cally required for restricting RIP2 ubiquitylation after MDP stim-
ulation. These findings indicate that A20 enzymatically modifies
diverse ubiquitylated target proteins, including RIP1, TRAF6, and
RIP2. Hence, like other E3 ligases and deubiquitylating enzymes,
A20 appears to act on multiple substrates.
A20’s physiological targets may be dictated partly by the
structural nature of the substrate and partly by K63-linked ubiq-
uitylation of the substrate. In this scenario, signaling intermedi-
ates that share certain structural features and that become dec-
orated with K63-linked polyubiquitin chains in response to
a specific ligand may become A20’s preferential enzymatic sub-
strates. Thus, although TRAF6 may be a dominant K63 ubiquity-
lated signaling intermediate during TLR-induced NFkB signalingImmunity 28, 381–390, March 2008 ª2008 Elsevier Inc. 387
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A20 restricts RIP2 ubiquitylation and NOD2 signals(Deng et al., 2000) and may also be involved in MDP-induced
signals (Abbott et al., 2004), our current data suggest that RIP2
is conjugated to K63-linked polyubiquitin chains after MDP
stimulation and that ubiquitylated RIP2 is the major target for
A20 during MDP-triggered signaling. The ability of A20 to recog-
nize both signaling intermediates and their ubiquitin chains is
consistent with recent structural data suggesting that A20 may
bind ubiquitin chains as well as exert enzymatic activity toward
ubiquitylated substrates (Penengo et al., 2006; Lee et al., 2006;
Komander and Barford, 2008).
Finally, A20’s multiple functions may play independent or ad-
ditive (or perhaps synergistic) roles in restricting immune
responses in vivo. These diverse functions suggest that even
modest changes in A20 expression or A20 activity may lead to
important changes in the intensity and character of immune
responses. Such changes may underlie recent genetic sugges-
tions that polymorphisms near or within the TNFAIP3 (A20)
gene are associated with inflammatory diseases in human
patients (Wellcome Trust Case Control Consortium, 2007;
Plenge et al., 2007; Thomson et al., 2007). Therefore, A20 may
be an outstanding therapeutic target for inflammatory diseases.
EXPERIMENTAL PROCEDURES
Mice and Cell Preparations
The generation of Tnfaip3/ mice was previously described (Lee et al., 2000).
Myd88/mice were generously provided by S. Akira and R. Medzhitov. Tnf/
and Ticam1lps2/lps2 mutant mice were purchased from JAX laboratories (Bar
Harbor, ME). All strains of mice were backbred to the C57BL/6J background
for at least six generations. Myd88/, Tnf/, and Ticam1lps2/lps2 mice were
interbred with Tnfaip3/ mice in the UCSF animal-care facility, and all proce-
dures were conducted according to IACUC approved protocols. BMDMs and
BMDCs were generated as previously described (Boone et al., 2004).
Antibodies and Cellular Reagents
Antibodies for cellular phenotyping were purchased from BD Biosciences (San
Jose, CA) and used at recommended dilutions. Cells were analyzed on
a FACSCalibur analyzer and quantitated using FlowJo software (Tree Star,
Incorporated, Ashland, OR). Antibodies for immunoprecipitation and immu-
noblotting experiments were obtained from commercial sources; anti-RIP2
(for immunoprecipitation: Cayman Chemical, Ann Arbor, MI; for immunoblott-
ing: Alexis biochemicals, San Diego, CA), anti-ubiquitin, anti-IKK-b, and
anti-IKKg (Santa Cruz Biotechnology, Santa Cruz, CA). ELISA analyses of cy-
tokine secretion were performed using assay kits according to manufacturer’s
protocols (BD Biosciences, San Jose, CA). MDP from Calbiochem (Leicester-
shire, UK) and Tri-DAP (L-Ala-D-Glu-meso-DAP) (kind gift from Stephen Girar-
din) were controlled for lack of endotoxin content by the Limulus amoebocyte
gelation activity test (LAL) performed using the QCL-1000 from BioWhittaker
(Verviers, Belgium), according to the manufacturer recommendations.
Plasmids
cDNA expression constructs for murine NOD2, RIP2, and A20 proteins were
generated by RT-PCR from normal murine cells, sequenced to confirm their
accuracy, and subcloned into pCMV expression constructs. cDNA expression
vectors for NOD1, NOD2, and RIP2 were described elsewhere (Kufer et al.,
2006).
Luciferase Reporter Assays
Human embryonic kidney cells (HEK293T) were stimulated with 20 nM MDP,
20 nM Tri-dap, or 10 mm forskolin 30 min before transient transfection with
75 ng of a NFkB or CRE luciferase reporter (Stratagene) and 25 ng of a b-ga-
lactosidase construct along with NOD1, NOD2, or RIP2 and A20 expressing
vectors using the Fugene 6 reagent (Roche diagnostics, Mannheim, Germany),
according to the manufacturer recommendations. For each transfection point,388 Immunity 28, 381–390, March 2008 ª2008 Elsevier Inc.total DNA was adjusted to 300 ng by empty vector pcDNA3.1. After 20 hr of
transfection, supernatants were discarded and cells were lysed in 100 ml of
lysis buffer (Tris pH 8 25 mM, MgCl2 8 mM, Triton X-100 1%, glycerol 15%,
DTT 1 mM) for 5 min at room temperature. Lysed cells were analyzed for lucif-
erase activity in lysis buffer complemented with luciferin, 2 mM, and ATP,
1 mM from Sigma Aldrich (St Quentin, France) using a Microlumat plus from
Berthold Technologies (Bad Wildbad, Germany). For each well, relative lucifer-
ase activity was normalized to b-galactosidase activity.
MDP Stimulation of Cells
Cells were pretreated 30 min before stimulation with cytochalasine D (Calbio-
chem, Leicestershire, UK) to a final concentration of 1 mM, then stimulated by
addition of endotoxin tested MDP (10 mg/ml) or MDP isomer in complete
medium. In some experiments, cytochalasin D was omitted. After 20 hr of
stimulation, supernatants were either analyzed directly or aliquoted and frozen
at 20C for subsequent cytokine assay by ELISA.
Cell-Free Deubiquitylation Assays
Cell-free deubiquitylation assays were performed as previously described
(Boone et al., 2004). Briefly, FLAG-RIP2 was transfected into 293T cells, after
which cells were lysed and ubiquitylated FLAG-RIP2 was immunoprecipitated
with anti-FLAG (RIP2) antibody. Ubiquitylated FLAG-RIP2 was then incubated
with either wild-type or mutant forms of recombinant bacterial N-terminal A20
protein and subsequently analyzed by immunoblotting for ubiquitin. Recombi-
nant N-terminal protein was prepared as previously described, with the
modification that N-terminal GST-A20 protein was cleaved with thrombin
and purified prior to use in the deubiquitylation assays (Boone et al., 2004).
Assays of Endogenous Protein Ubiquitylation
BMDMs were stimulated with 10 mg/ml MDP, lysed in RIPA lysis buffer, boiled
in 1%SDS, diluted 1:10 in RIPA buffer, immunoprecipitated with antibodies
specific for either RIP2 (Cayman Chemical) or TRAF6 (Santa Cruz), and
analyzed by immunoblotting with antibodies to ubiquitin (Santa Cruz, P4D1),
RIP2 (Alexis), or TRAF6 (EMD bioscience).
In Vivo MDP Assays
Mice were injected intraperitoneally with 25 mg/kg of MDP or H2O. Four hours
later, serum was obtained and analyzed by ELISA for IL-6 levels according to
manufacturer’s instructions (BD Biosciences).
SUPPLEMENTAL DATA
Supplemental Data include one figure and can be found with this article online
at http://www.immunity.com/cgi/content/full/28/3/381/DC1/.
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